PRESS RELEASE published on 02/04/2025 at 11:00, 11 months 18 days ago Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment Mallia Therapeutics partners with Northway Biotech to develop a safe and effective topical sCD83 treatment for alopecia, leveraging biologics manufacturing expertise Biologics Manufacturing Alopecia Market Mallia Therapeutics Northway Biotech CD83 Treatment
PRESS RELEASE published on 02/04/2025 at 11:00, 11 months 18 days ago Volatus Aerospace Inc. annonce un partenariat stratégique avec Dufour Aerospace pour améliorer les missions de transport aérien, de surveillance, d'inspection et de cartographie grâce à une technologie avancée d’aéronefs VTOL Volatus Aerospace Inc. ajoute un drone Aero2 hybride-électrique à longue endurance et charge lourde, offrant flexibilité et efficacité. Partenariat stratégique avec Dufour Aerospace AG Partenariat Stratégique Volatus Aerospace Drone Aero2 Dufour Aerospace AG Technologie VTOL
PRESS RELEASE published on 02/04/2025 at 10:47, 11 months 18 days ago Quarterly Activities Report for the period ending 31 December 2024 Vulcan Energy achieves significant milestones in its Phase One Lionheart Project with key highlights including successful financing, partnership with BASF, and lithium hydroxide production Financing BASF Lithium Production Vulcan Energy Phase One Lionheart Project
PRESS RELEASE published on 02/04/2025 at 10:35, 11 months 18 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce un recentrage stratégique pour se concentrer sur le développement de médicaments early-stage et assurer une croissance durable. La société cherche un accord de financement à long terme Développement Financement Restructuration Médicaments Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 11 months 18 days ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
REGULATED PRESS RELEASE published on 02/04/2025 at 10:18, 11 months 18 days ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 31 janvier 2025 Déclaration mensuelle du nombre total d’actions et de droits de vote composant le capital au 31 janvier 2025, conformément à l'article L 233-8 du Code de Commerce et à l'article 223-16 du Règlement Général de l’AMF Capital Droits De Vote Actions Déclaration Mensuelle AMF
PRESS RELEASE published on 02/04/2025 at 10:18, 11 months 18 days ago KION with strong financial year 2024 – efficiency program resolved to strengthen resilience KION Group AG reports strong financial year 2024 with increased profitability. Efficiency program launched to enhance resilience and competitiveness Financial Year 2024 Résilience KION GROUP AG Competitiveness Efficiency Program
PRESS RELEASE published on 02/04/2025 at 10:17, 11 months 18 days ago EQS-Adhoc: KION GROUP AG: Efficiency program with impact on 2025 financial year; preliminary group results for 2024 financial year KION GROUP AG implements efficiency program for 2025, impacting 2026 finances. Preliminary 2024 results exceed expectations. Details in upcoming report Preliminary Results Cost Savings KION GROUP AG Efficiency Program 2025 Financial Year
REGULATED PRESS RELEASE published on 02/04/2025 at 10:15, 11 months 18 days ago OVHcloud lance Object Storage Standard 3-AZ dans la région de Paris, offrant une haute résilience pour les données OVHcloud lance Object Storage Standard 3-AZ dans la région de Paris, offrant une haute résilience pour les données. Le nouveau modèle de déploiement permet une continuité de service pour les charges de travail cloud critiques OVHcloud Cloud Résilience Object Storage 3-AZ
REGULATED PRESS RELEASE published on 02/04/2025 at 10:15, 11 months 18 days ago OVHcloud launches Object Storage Standard 3-AZ in Paris region, offering high resiliency for data OVHcloud launches Object Storage Standard 3-AZ in Paris region, enhancing data resiliency. Multi-availability zone deployment model for critical cloud workloads OVHcloud Paris Region Object Storage Data Resiliency Multi-availability Zone
Published on 01/22/2026 at 15:50, 1 minute ago Premier American Uranium Announces Upsize of Bought Deal Private Placement to C$13 Million
Published on 01/22/2026 at 15:00, 51 minutes ago Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Published on 01/22/2026 at 14:55, 56 minutes ago Sparton Resources Inc. Final Approval for Private Placement and Updates
Published on 01/22/2026 at 14:30, 1 hour 21 minutes ago Loar Holdings Inc. Announces the Acquisition of Harper Engineering Company
Published on 01/22/2026 at 14:30, 1 hour 21 minutes ago Solitario Adds Bright Angel Gold - Copper Project, Further Diversifying Its Property Portfolio
Published on 01/22/2026 at 15:47, 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: Rio Tinto plc and Rio Tinto Limited
Published on 01/22/2026 at 15:46, 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Published on 01/22/2026 at 15:35, 16 minutes ago EQS-Adhoc: Covestro AG decides to apply for switch from the Prime Standard to the General Standard of the Frankfurt Stock Exchange
Published on 01/22/2026 at 14:42, 1 hour 9 minutes ago BaFin reduces SREP capital requirements (P2R) for flatexDEGIRO Group by 25 basis points to 2.50%
Published on 01/22/2026 at 08:45, 7 hours 6 minutes ago Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:45, 7 hours 6 minutes ago La démarche proactive d’approvisionnement en électricité bas carbone d’Air Liquide prend de l’ampleur, avec 3 TWh par an de PPA supplémentaires démarrés en 2025
Published on 01/22/2026 at 08:29, 7 hours 22 minutes ago bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
Published on 01/22/2026 at 07:00, 8 hours 51 minutes ago 2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Published on 01/22/2026 at 07:00, 8 hours 51 minutes ago Chiffre d'affaires 2025 : 918 M€ à devises constantes (+4.3%) - 899 M€ à devises courantes (+2.1%)